Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE)
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 22-011679
NCT ID: NCT05605093
Sponsor Protocol Number: INSIGHT 018/ACTIV
About this study
The purpose of this study is to improve standard of care by ensuring an agile research infrastructure with an ability to rapidly assess interventions during epidemic transmission of one or more respiratory pathogens adversely affecting public health.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria - STRIVE Platform:
- Age ≥ 18 years.
- Informed consent for trial participation.
- Hospital admission (or boarding in an emergency department or other area awaiting hospital admission) with signs and/or symptoms of a respiratory infection.
Exclusion Criteria - STRIVE Platform:
- The patient is expected to be discharged from the hospital within the next 24 hours.
- Medical condition other than the acute respiratory infection (and its manifestations) that is likely to result in death within 7 days of randomization.
- Moribund condition, defined as prior cardiac arrest during this hospitalization and life expectancy less than 48 hours of randomization.
- Patient undergoing comfort care measures only such that treatment focuses on end-of-life symptom management over prolongation of life.
- Expected inability or unwillingness to participate in study procedures.
- In the opinion of the investigator, participation in a trial is not in the best interest of the patient.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 11/9/22. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Zelalem Temesgen, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available